About the Cancer Stem Cells and Tumor Heterogeneity Session
Cancer stem cells (CSCs) are a small population of cells within tumors that possess the ability to self-renew, drive tumor growth, and are believed to be responsible for relapse and metastasis. These cells are highly resistant to conventional therapies, which often fail to target the CSCs effectively. Tumor heterogeneity, the presence of diverse cell types within a single tumor, further complicates treatment strategies. Researchers are focusing on understanding the molecular characteristics that distinguish CSCs from normal stem cells and developing therapies that specifically target these cells. Overcoming the challenges posed by CSCs and tumor heterogeneity could significantly improve cancer treatment outcomes and reduce the likelihood of relapse.
Topics Covered in Cancer Stem Cells and Tumor Heterogeneity
Self-Renewal Pathways
Stemness Markers
Cellular Plasticity
Clonal Evolution
Single-Cell Sequencing
Dormancy & Relapse
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Stem Cells and Tumor Heterogeneity Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Stem Cells and Tumor Heterogeneity work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Stem Cells and Tumor Heterogeneity research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Stem Cells and Tumor Heterogeneity track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Stem Cells and Tumor Heterogeneity Conference 2027 — FAQs
What is the Cancer Stem Cells and Tumor Heterogeneity track at CIOC 2027?
The Cancer Stem Cells and Tumor Heterogeneity track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Stem Cells and Tumor Heterogeneity. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Stem Cells and Tumor Heterogeneity sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Stem Cells and Tumor Heterogeneity are all welcome — whether presenting or attending.
Can I present my research in the Cancer Stem Cells and Tumor Heterogeneity track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Stem Cells and Tumor Heterogeneity sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Stem Cells and Tumor Heterogeneity track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.